How Excimer Laser Treatment Works for Vitiligo

The 308-nm excimer laser is one of the more effective targeted phototherapy tools for repigmenting vitiligo patches, with studies reporting that roughly 60 percent of treated lesions can reach substantial color return when sessions are kept up long enough. It works by delivering a concentrated beam of ultraviolet B light at a specific wavelength directly onto depigmented skin, sparing the surrounding normal skin from unnecessary UV exposure. But the results depend heavily on where the patches are, what other treatments you combine with the laser, and how many sessions you can commit to.

How the Laser Restores Color

Vitiligo patches lose their pigment because immune cells in the skin destroy melanocytes, the cells responsible for producing melanin. The 308-nm excimer laser counteracts this by triggering the death of those destructive T cells in the treated area, essentially clearing the way for melanocytes to recover and repopulate.

¹ Early research on psoriasis showed that the excimer laser was more potent at inducing this T cell death than standard narrowband UVB phototherapy, and that same immune-calming effect appears to drive results in vitiligo as well.²

But killing off rogue immune cells is only half the story. The new pigment has to come from somewhere. Melanocyte precursor cells hiding in hair follicles are the main reservoir, and a 2025 study found that the excimer laser penetrates deeper into hair follicles and activates more of these melanocyte precursor cells than excimer lamp devices. The laser also caused less surface-level skin cell damage while reaching those deeper follicular targets, which may explain why repigmentation often begins as tiny dots of color around individual hair follicles before spreading outward.³ This follicular pattern is something you and your dermatologist can actually see during treatment, and it is generally a good sign that the process is working.

What the Numbers Look Like

In a study of 105 vitiligo lesions treated with the excimer laser, about 60 percent achieved more than 75 percent repigmentation. Another roughly 11 percent reached 51 to 75 percent color return, and about 9 percent showed moderate improvement. On the other end, about 11 percent of lesions showed no response at all. The average number of sessions needed to get any noticeable repigmentation was around 17, and reaching that higher tier of color return took closer to 20 sessions on average.⁴

Those numbers provide a reasonable benchmark, but individual results swing widely. A small case series of facial vitiligo patients treated with the excimer laser plus a topical vitamin D analog (calcipotriene) saw all three patients reach more than 75 percent repigmentation within 10 to 20 weeks.⁵ The face tends to be the most responsive location, which is fortunate since it is also where vitiligo tends to be most distressing. Other areas are a different story entirely.

Body Location Makes or Breaks the Outcome

If there is one thing the research is consistent about, it is that anatomy matters enormously. The face, neck, and trunk respond far better than hands, feet, elbows, knees, and other bony prominences. One study found that lesions in “UV-sensitive” areas like the face and trunk had a 57 percent rate of achieving strong repigmentation, compared to just under 16 percent for lesions on bony prominences and extremities.⁶

A separate study broke this down even further. Lesions on the face, trunk, arms, and legs began repigmenting after about 13 treatments on average, while spots on elbows, wrists, the backs of hands, knees, and the tops of feet needed around 22 treatments. After 10 weeks, a quarter of the better-responding lesions had reached more than 75 percent repigmentation, but only about 2 percent of the stubbornly resistant group hit that mark. Finger lesions were the worst performers, showing zero repigmentation in any treated patch.⁷

The reason likely traces back to the melanocyte reservoir in hair follicles. The face and trunk are densely hairy (even if the hair is fine and barely visible), so there are more melanocyte precursors available to migrate outward and repopulate the depigmented patch. Fingertips and bony areas have far fewer hair follicles, so the laser has fewer cells to recruit. This is also why patches of vitiligo that have turned the overlying hair white (a sign of follicular melanocyte loss) tend to respond poorly regardless of where they are on the body.

How It Compares to Whole-Body Phototherapy

Narrowband UVB (NBUVB) phototherapy delivered in a full-body booth is the most widely used light-based treatment for vitiligo. The excimer laser uses the same general principle but focuses the energy on individual patches. Head-to-head comparisons generally favor the excimer laser for speed and degree of repigmentation, especially for localized disease.

A multicentre controlled study found that the excimer laser produced excellent repigmentation (the highest grade on their scoring scale) in about 38 percent of treated lesions, compared to only 6 percent with NBUVB. When combining excellent and good responses, the laser still came out ahead.⁸ Another study using a within-patient comparison (different patches on the same person treated with each method) found that the gap between the laser and NBUVB widened with more sessions. By 20 treatments, the laser-treated patches had nearly twice the repigmentation scores of the NBUVB-treated patches.⁹

The practical advantage of targeted therapy is obvious if your vitiligo is limited to a few patches. You get higher UV doses right where you need them, with no unnecessary exposure to the rest of your skin. For widespread vitiligo covering large portions of the body, though, treating each spot individually with a laser becomes impractical and time-consuming, and whole-body NBUVB is the more sensible choice. The excimer laser is best suited for people with localized or limited disease.¹⁰

Excimer Laser Versus Excimer Lamp

This distinction confuses a lot of people. The excimer laser and the excimer lamp both emit 308-nm UV light, but they deliver it differently. The laser produces a coherent, focused beam, while the lamp emits a broader, less focused light over a wider area. A systematic review with meta-analysis found no significant difference in efficacy between the two devices, whether measured at the 50-percent or 75-percent repigmentation threshold.¹¹ Randomized head-to-head trials have confirmed this, though the lamp tends to cause more skin redness at the same dose.¹²

Why does this matter? Excimer lamps are substantially cheaper to purchase and maintain than excimer lasers. If the clinical outcomes are essentially the same, the lamp could be a more accessible option for clinics that cannot afford the laser. For patients, the practical difference is minimal: both require roughly the same number of sessions and produce similar repigmentation patterns. Where the laser may have a subtle edge is in that deeper follicular penetration noted in the 2025 study, though whether that translates to meaningfully better long-term outcomes in clinical practice is still an open question.

Combination Therapies

The excimer laser works well on its own, but combining it with topical or systemic medications often pushes the response rate higher, particularly for stubborn patches. The most studied combinations involve topical calcineurin inhibitors like tacrolimus, and the evidence here is genuinely compelling.

In a landmark study, patches treated with both the excimer laser and topical tacrolimus achieved 75 percent or greater repigmentation in 70 percent of cases, compared to just 20 percent of patches treated with the laser alone. The difference was even more dramatic in areas that typically resist UV therapy (hands, elbows, knees): 60 percent of combination-treated spots in those difficult areas hit the 75 percent repigmentation mark, while none of the laser-only spots in those same areas did.¹³ That is a meaningful upgrade, especially for people whose vitiligo sits on the hands and joints.

A larger retrospective study of 159 patients with segmental vitiligo (the type that follows a nerve-like distribution on one side of the body) used a triple combination of excimer laser, topical tacrolimus, and a short course of oral corticosteroids. About half of patients achieved 75 percent or greater repigmentation after a median treatment period of roughly a year, with about 14 percent reaching complete repigmentation.¹⁴

The newest frontier is combining the excimer laser with JAK inhibitors, a class of drugs that tamp down immune signaling. A multicenter randomized trial found that adding the oral JAK inhibitor baricitinib to excimer laser treatment yielded a repigmentation rate about 14 percentage points higher than conventional treatment alone.¹⁵ This combination is still fairly new in dermatology practice, but it reflects a broader trend: using immunomodulatory medications alongside targeted phototherapy to attack vitiligo from two angles simultaneously.

Treating Children

Vitiligo in children carries a particular emotional weight. Kids can be self-conscious about visible patches, and parents naturally worry about long-term UV exposure. The excimer laser has been evaluated in pediatric populations with generally encouraging results. In a study of 30 children, about 57 percent of patients (with half of the treated patches) achieved more than 50 percent repigmentation. Just like in adults, the face, neck, and trunk responded best. Side effects were limited to mild and temporary reactions like slight redness.¹⁶

Because the laser treats only the affected patch, total UV exposure is far lower than with whole-body phototherapy. That is a meaningful advantage in children, where cumulative UV dose over a lifetime is a more pressing concern. Early-phase research has also looked at combining the excimer laser with oral JAK inhibitors in children with progressive vitiligo, with results showing significantly higher repigmentation rates in the combination group along with good tolerability.¹⁷ These combination approaches are not yet standard of care in pediatrics, but the data is heading in an encouraging direction.

Dosing Is Not One-Size-Fits-All

One practical detail that often gets lost in patient discussions is that the starting dose of the excimer laser needs to be calibrated to your specific skin. Dermatologists typically determine the minimal erythema dose, which is the lowest UV dose that causes slight pinkness, and then set the treatment dose as a multiple of that threshold. This threshold varies significantly not just between people but between body sites on the same person. A study of Asian vitiligo patients found that mucosal regions (like the lips) have a lower threshold than other areas, meaning those spots need a gentler starting dose to avoid burns.¹⁸ Your dermatologist should be adjusting the dose for each treated area rather than using a blanket setting across all patches.

Sessions are typically spaced two to three times per week, with the dose gradually increased based on your skin’s response. Mild redness after a session is expected and actually desired: it signals that the UV dose is in the therapeutic range. Blistering, on the other hand, means the dose was too high and needs to be dialed back. Most treatment courses run somewhere between 20 and 40 sessions before results are assessed, though some people see early follicular repigmentation in as few as 6 to 10 weeks of treatment.¹⁹

How Long Does Repigmentation Last?

This is the question most patients really want answered, and honestly, the evidence here is thinner than you might expect. One retrospective study with a follow-up period averaging about 19 months found that only one patient had relapsed during that window, which sounds reassuring.²⁰ A separate study specifically tracking durability found that laser-induced repigmentation was persistent in most cases when checked 12 months after treatment ended.²¹

But vitiligo is an autoimmune condition, and the underlying immune dysfunction does not disappear after phototherapy. Many dermatologists recommend periodic maintenance sessions or topical treatments (particularly tacrolimus or corticosteroids) to preserve the regained color. Without some form of maintenance, depigmentation can gradually creep back, especially if the disease is still active elsewhere. If your vitiligo is stable (no new patches appearing, no existing patches expanding), the repigmentation you gain is more likely to hold. If your disease is actively progressing, relapse risk is higher, and combining the laser with systemic treatments to calm the immune system first may produce more durable outcomes.

Segmental Versus Non-Segmental Vitiligo

These two subtypes of vitiligo behave quite differently, and they respond to the excimer laser differently too. Non-segmental vitiligo is the more common form, presenting as symmetrical patches on both sides of the body. Segmental vitiligo follows a nerve-like distribution on one side and tends to stabilize more quickly but can be stubbornly resistant to treatment once established. A Taiwanese study using excimer light therapy found that segmental lesions were actually a predictor of poorer treatment response in multivariate analysis.²² This may be because segmental vitiligo involves more complete destruction of the melanocyte reservoir in the affected area, leaving fewer cells for the laser to reactivate. That said, the combination approach of excimer laser plus tacrolimus plus corticosteroids described earlier was studied specifically in segmental vitiligo and achieved reasonable results, suggesting that multi-pronged treatment can partially overcome this limitation.

Beyond the Skin

Vitiligo is not just a cosmetic issue, and the benefits of repigmentation extend beyond appearance. A study specifically measuring quality of life found that excimer laser treatment significantly improved patients’ self-reported wellbeing across multiple domains. Patients reported less life disturbance and greater life satisfaction after treatment.²³ This matters because the psychological burden of vitiligo is well documented: anxiety, depression, social avoidance, and a persistent sense of stigma affect many people with the condition, particularly when patches are on the face or hands.

Objective monitoring tools are also becoming more sophisticated. Reflectance confocal microscopy and dermoscopy can now help dermatologists assess vitiligo staging and track treatment response at a cellular level, rather than relying entirely on visual grading by eye.²⁴ These imaging tools can reveal early melanocyte repopulation before it is visible to the naked eye, potentially helping clinicians decide whether to continue, intensify, or change course. For patients, this translates to earlier feedback on whether the treatment is working, rather than waiting months to see visible color change and wondering if the sessions are pointless.